South Africa: The 6-Monthly Anti-HIV Jab Could End Aids in South Africa by 2032

South Africa: The 6-Monthly Anti-HIV Jab Could End Aids in South Africa by 2032

A modelling study shows the six-monthly anti-HIV jab, lenacapavir, could end Aids in SA by 2032 -- but only if between two and four million HIV-negative people in the country would need to use the jab every year over the next eight years. How much should we pay for it?

Gilead is urged to rework licensing deals for groundbreaking HIV prevention drug

A group of academics is arguing that countries seeking access to a groundbreaking HIV prevention drug from Gilead Sciences should issue compulsory licenses if the company fails to modify an existing licensing program with half a dozen generic makers. In an essay in Clinical Infectious Diseases, they complained Gilead pursued voluntary licenses that are too restrictive, which will delay or deny access to its drug. Called lenacapavir, the medicine…

WHO launches regional roadmap for triple elimination of mother-to-child-transmission of HIV, Syphilis, and Hepatitis B

Saima Wazed, the Regional Director of the World Health Organization (WHO) South-East Asia, on Thursday highlighted the significant progress made in the Asia-Pacific region in protecting children and families from HIV, syphilis, and hepatitis B. Speaking at the launch of the regional roadmap for the triple elimination of mother-to-child transmission of these infections for the 2024-2030 period, Wazed stressed the importance of continued efforts i…

Ground-breaking HIV, syphilis testing initiative

Amid soaring rates of HIV and syphilis in Canada – with Indigenous communities in the Prairies being hardest hit – a team of Indigenous leaders and HIV advocates, researchers, health care workers and people with lived experiences, including HIV, have created The Ayaangwaamiziwin Centre. This Centre is a ground-breaking initiative to “test, treat and link to culturally safe care” 10,000+ people at risk for HIV and/or syphilis in the Prairies and …

New five-year roadmap guides Asia Pacific countries toward elimination of mother-to-child HIV, syphilis and hepatitis B transmission

BANGKOK, 10 April, 2025—Every child deserves the best start to a healthy life, free from preventable diseases and infections. To this end, today the WHO, UNICEF and UNAIDS launched the Regional Roadmap for the Triple Elimination of Mother-to-Child Transmission (EMTCT) of HIV, Syphilis and Hepatitis B in the Asia and Pacific Region (2024–2030). This resource offers guidance to strengthen national strategies and operational plans to end these thre…